vast therapeutics

KNOW Bio incubator forms digestive health subsidiary

Posted by WRAL TechWire | Mar 28, 2019

KNOW Bio has created a new operating subsidiary to extend that work into gastroenterology. Here’s a look.

Vast Therapeutics Lands $15M Series A funding, $300K from CF Foundation

Posted by WRAL TechWire | Jan 15, 2019

Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.

KNOW Bio raises another $1.1M in equity

Posted by WRAL News | Dec 10, 2018

Formerly known as Novoclem Therapeutics, Inc., KNOW Bio, is a Research Triangle-based incubator for platform-based medical technology and biotechnology companies.

Durham’s Vast Therapeutics gets Series A financing to fight superbugs

Posted by WRAL News | Dec 10, 2018

The investment provides Vast with funding to advance its nitric oxide technology invented in the laboratory of Prof. Mark Schoenfisch, Vast’s president.